Mack Gene insider trades
Mack Gene has filed 5 Form 4s with the SEC that we hold, all for Gain Therapeutics, Inc. (GANX), as CEO, President, Director. Across all of them we count 1 purchase worth $14.5K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 14,400 shares of Gain Therapeutics, Inc. worth $14.5K, dated 2024-08-09. The first filing on our record is dated 2024-04-08 and the latest 2026-03-26.
Gain Therapeutics, Inc. (GANX)
CEO, President, Director · 5 filings · 1 purchase or sale
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2024-08-09 | P, purchase reported on Form 4 | 14,400 | $14.5K | 2024-08-12 | SEC |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1737979) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
